Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Nasdaq 100 E-Mini Sep '23 (NQU23)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CME]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ rootItem.symbol ]]underlying price [[ rootItem.lastPrice ]] [[ rootItem.priceChange ]] ([[ rootItem.percentChange ]]) [[ rootItem.tradeTime ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Nasdaq 100 E-Mini Futures Market News and Commentary

Stocks Finish Higher on U.S. Economic Optimism

What you need to know…

The S&P 500 Index ($SPX) (SPY) Friday closed up +0.41%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.39%.

Stocks on Friday settled moderately higher, with the S&P 500 posting a 4-1/4 month high, the Dow Jones Industrials posting a 1-3/4 year high, and the Nasdaq 100 climbing to a 1-week high.  Stocks Friday recovered from early losses and rallied after U.S. economic reports bolstered the outlook for an economic soft landing.  Stocks initially moved lower as bond yield jumped after the monthly U.S. payroll report showed a larger-than-expected increase in November nonfarm payrolls and an unexpected decline in the unemployment rate to a 4-month low, dampening speculation that the Fed will cut interest rates as early as Q1 next year.

However, stocks reversed and moved higher as inflation expectations eased, and a larger-than-expected increase in the University of Michigan’s U.... Read more

Contract Specifications

See More
Contract
E-Mini Nasdaq 100
Contract Size
$20 times Index
Tick Size
0.25 points ($5.00 per contact)
Trading Hours
5:00p.m. - 4:00p.m. (Sun-Fri) (Settles 3:00p.m.) CST
Exchange
CME
Point Value
$20
Margin/Maintenance
$18,480/16,800
First Notice Date
09/15/23
Expiration Date
09/15/23 (expired)

Seasonal Chart

Nasdaq 100 E-Mini Sep '23
Average Price Chart for 5 Prior Sep Contracts

Commitment of Traders Positions as of Dec 5, 2023

View Chart Details
Commercials - Long / Short
155,418 (-10,911)
168,998 (-8,233)
Non-Commercials - Long / Short
75,200 (-3,502)
66,798 (-4,626)
Dealers / Intermediary - Long / Short
54,064 (+1,029)
108,214 (-11,534)
Asset / Manager - Long / Short
107,327 (-3,947)
17,805 (+1,857)
Leveraged Funds - Long / Short
46,370 (-543)
72,326 (+23,280)
Other Reportables - Long / Short
8,818 (-12,332)
23,412 (-27,842)
Get Realtime - Quotes and Charts for Futures Traders. Learn More >>

Price Performance

See More
Period Period Low Period High Performance
1-Month
14,609.25 +5.65%
on 08/18/23
15,661.25 -1.44%
on 09/01/23
+328.70 (+2.18%)
since 08/15/23
3-Month
14,609.25 +5.65%
on 08/18/23
16,062.75 -3.91%
on 07/19/23
+61.20 (+0.40%)
since 06/15/23
52-Week
10,950.75 +40.95%
on 10/13/22
16,062.75 -3.91%
on 07/19/23
+3,082.20 (+24.95%)
since 09/15/22

More Nasdaq 100 E-Mini Quotes

All Futures Prices
Please wait...

Most Recent Stories

More News
CPI, Rate Announcement and Other Key Thing to Watch This Week

Last week was pretty quiet with S&P 500 ($SPX) (SPY) trading in a range between 4,546 and 4,609.

$SPX : 4,604.37 (+0.41%)
SPY : 460.20 (+0.43%)
MDB : 381.79 (-0.64%)
GOOGL : 134.99 (-1.42%)
ADBE : 610.01 (+0.20%)
COST : 610.78 (-0.03%)
Nvidia Stock Is Off Its Highs but Has Huge Upside - Ideal for Option Put Short Sellers

Nvidia stock has dropped from its recent high of $504.09 on Nov. 20 after its blowout Q3 results. At $475 NVDA is just above its average trading range. This is ideal for put option short sellers.

What Mark Zuckerberg's Massive Meta Stock Dump Means for Investors

Meta Platforms stock has more than doubled in 2023, allowing investors to generate outsized gains this year. But is META stock a good buy at the current valuation?

AMZN : 147.42 (+0.37%)
NVDA : 475.06 (+1.95%)
NVDA : 475.06 (+1.95%)
CRM : 250.81 (+0.79%)
1 Dividend Aristocrat to Scoop Up at a Discount This December

This retail stock offers seasonal strength for the holiday season - plus compelling value and a tempting dividend yield after a rocky performance in 2023.

Is Beaten-Down Beyond Meat a Good Buy Under $10?

Struggling BYND has lost 96% of its value from all-time highs, but the stock still doesn't look like a good bargain for investors. Here's why.

TSN : 51.38 (-0.31%)
The Giving Season: 4 Things to Know About Donating to Charities

The holidays, for many, are also prime time for donations. We look over a few key things to consider this giving season, including taxes, charity research, and more.

Stocks Finish Higher on U.S. Economic Optimism

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%....

Elon Musk Intensifies Feud with Disney CEO Bob Iger Over Advertising Ethics

Elon Musk, the enigmatic entrepreneur behind companies like SpaceX and Tesla (TSLA), has intensified his public spat with Disney (DIS) CEO Bob Iger. In a series of provocative posts on the social media...

DIS : 92.82 (+0.51%)
META : 332.75 (+1.89%)
TSLA : 243.84 (+0.49%)
WBD : 11.47 (+6.01%)
PARA : 16.85 (+12.11%)
AAPL : 195.71 (+0.74%)
Honeywell Bolsters Building Automation with $5 Billion Carrier Unit Purchase

Honeywell International (HON) has announced a significant expansion of its business portfolio with the acquisition of Carrier Global’s (CARR) security business for approximately $5 billion. This strategic...

HON : 194.61 (-1.61%)
CARR : 55.27 (+4.50%)
Gene Therapy Breakthrough: Two Treatments Approved by FDA for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) has taken a groundbreaking step by approving two gene therapies for sickle cell disease, marking a significant advancement in the treatment of this debilitating...

PFE : 28.78 (+0.52%)
BLUE : 2.86 (-40.54%)
CRSP : 64.54 (-8.08%)
VRTX : 350.15 (-1.07%)

Barchart Trading Guide

The Barchart Trading Guide is a Buy Signal with a Soft Signal Strength.

Key Turning Points

3rd Resistance Point 15,628.47
2nd Resistance Point 15,576.23
1st Resistance Point 15,505.72
Last Price 15,435.20s
1st Support Level 15,382.97
2nd Support Level 15,330.73
3rd Support Level 15,260.22

See More

52-Week High 16,062.75
Last Price 15,435.20s
Fibonacci 61.8% 14,109.97
Fibonacci 50% 13,506.75
Fibonacci 38.2% 12,903.53
52-Week Low 10,950.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar